- Home
- / Kaken Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Kaken Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥3.9 K
2024-10-29
Market Capitalization
¥147.6 B
2024-10-29
Revenue
¥94 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JPY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 98.4B | 94.2B | 89.2B | 75.0B | 76.0B | 73.0B | 72.0B | 94.0B |
| Cost of goods sold | 40.5B | 38.4B | 36.7B | 32.0B | 32.2B | 31.2B | 31.1B | 33.2B |
| Gross profit | 57.9B | 55.7B | 52.6B | 43.0B | 43.8B | 41.8B | 41.0B | 60.8B |
| Gross profit margin, % | 58.9% | 59.2% | 58.9% | 57.3% | 57.6% | 57.3% | 56.9% | 64.7% |
| Operating expense total | 28.3B | 29.0B | 23.7B | 22.9B | 24.3B | 31.3B | 28.7B | 37.2B |
| Depreciation and amortization | 2.1B | 2.2B | 2.6B | 2.3B | 5.5B | 4.4B | 2.8B | 4.0B |
| EBITDA | 29.6B | 26.7B | 28.8B | 20.1B | 19.6B | 10.5B | 12.2B | 23.6B |
| EBITDA margin, % | 30.1% | 28.4% | 32.3% | 26.8% | 25.7% | 14.4% | 17.0% | 25.1% |
| EBIT | 27.3B | 24.5B | 26.1B | 18.1B | 13.4B | 6.4B | 9.4B | 19.5B |
| EBIT margin, % | 27.8% | 26.0% | 29.3% | 24.1% | 17.6% | 8.8% | 13.0% | 20.8% |
| Interest income | 5.0M | 6.0M | 7.0M | 8.0M | 6.0M | 7.0M | 8.0M | 77.0M |
| Interest expense | 16.0M | 17.0M | 17.0M | 17.0M | 17.0M | 17.0M | 17.0M | 28.0M |
| Pre tax profit | 27.7B | 24.9B | 26.6B | 18.7B | 13.9B | 6.8B | 9.8B | 19.4B |
| Income tax expense | 8.6B | 7.1B | 7.2B | 5.3B | 4.3B | 1.4B | 1.8B | 5.5B |
| Net Income | 19.0B | 17.8B | 19.4B | 13.4B | 9.5B | 5.4B | 8.0B | 13.9B |